Literature DB >> 16952624

Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.

Sang Eun Lee1, Seok-Soo Byun, Jin Kyu Oh, Sang Chul Lee, In Ho Chang, Gheeyoung Choe, Sung Kyu Hong.   

Abstract

PURPOSE: We investigated the prognostic significance of macroscopic tumor necrosis in renal cell carcinoma.
MATERIALS AND METHODS: We retrospectively analyzed the records of 485 patients who underwent surgical treatment for organ confined or metastatic renal cell carcinoma. The presence or absence of tumor necrosis was evaluated based on macroscopic description of the tumor, and tumors were considered necrotic only if they exhibited more than 10% macroscopic necrosis.
RESULTS: Macroscopic tumor necrosis was identified in 27% of total patients. Patients with macroscopic necrotic renal cell carcinoma were more likely to have larger tumor, metastatic disease, higher local stage and higher tumor grade (all p < 0.001). Pathological features of microvascular invasion (p = 0.026) and sarcomatoid differentiation (p = 0.002) along with several laboratory findings were also observed to be associated with macroscopic tumor necrosis. Among the total subjects those without macroscopic tumor necrosis had significantly higher progression-free (p < 0.0001) and disease specific survival (p < 0.0001). When survival analysis was limited to nonmetastatic tumors only, the same logic applied, which was not the case for the patients with metastatic disease (p > 0.05). Among the different histological subtypes of renal cell carcinoma, macroscopic tumor necrosis was observed to have a significant impact only for the clear cell subtype. In patients with nonmetastatic RCC multivariate analysis revealed that macroscopic tumor necrosis (p = 0.004) was an independent prognostic predictor of disease specific survival along with pathological T stage, tumor grade and tumor size.
CONCLUSIONS: Our results suggest that macroscopic tumor necrosis may be a reliable prognostic indicator for nonmetastatic clear cell renal cell carcinoma which should routinely be examined for during pathological analysis.

Entities:  

Mesh:

Year:  2006        PMID: 16952624     DOI: 10.1016/j.juro.2006.06.021

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Prognostic factors in renal cell carcinoma.

Authors:  Alessandro Volpe; Jean Jacques Patard
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

2.  Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma.

Authors:  Shutaro Hori; Kazuaki Shimada; Yoshinori Ino; Seiji Oguro; Minoru Esaki; Satoshi Nara; Yoji Kishi; Tomoo Kosuge; Yukinori Hattori; Aoi Sukeda; Yuko Kitagawa; Yae Kanai; Nobuyoshi Hiraoka
Journal:  Virchows Arch       Date:  2016-10-05       Impact factor: 4.064

3.  Microvascular invasion as a prognostic indicator in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Hai Huang; Xiu-Wu Pan; Yi Huang; Dan-Feng Xu; Xin-Gang Cui; Lin Li; Yi Hong; Lu Chen; Yi Gao; Lei Yin
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Factors affecting the time to recurrence after radical nephrectomy for localized renal cell carcinoma.

Authors:  Hee-Seo Son; Seung Hyun Jeon; Sung-Goo Chang
Journal:  Korean J Urol       Date:  2013-11-06

5.  Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma.

Authors:  Hyun-Jung Lee; Zhe Long Liang; Song Mei Huang; Jae-Sung Lim; DO-Young Yoon; Hyo-Jin Lee; Jin Man Kim
Journal:  Oncol Lett       Date:  2011-12-02       Impact factor: 2.967

Review 6.  The changing face of renal cell carcinoma pathology.

Authors:  Hakan Aydin; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

7.  Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.

Authors:  Hakushi Kim; Chie Inomoto; Takato Uchida; Hiroyuki Furuya; Tomoyoshi Komiyama; Hiroshi Kajiwara; Hiroyuki Kobayashi; Naoya Nakamura; Akira Miyajima
Journal:  Int J Oncol       Date:  2018-02-28       Impact factor: 5.650

8.  The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Zhenlei Zha; Hu Zhao; Yejun Feng; Lijin Zhang; Bin Wu
Journal:  Cancer Manag Res       Date:  2018-06-22       Impact factor: 3.989

9.  Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naïve, unresectable metastatic renal cell carcinoma.

Authors:  Sung Han Kim; Weon Seo Park; Sun Ho Kim; Ho Kyung Seo; Jae Young Joung; Kang Hyun Lee; Jinsoo Chung
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

10.  Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC).

Authors:  Jinyan Wei; Jianhong Zhao; Xueling Zhang; Dan Wang; Wenjuan Zhang; Zhiping Wang; Junlin Zhou
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.